Imunon Inc
IMNN8.760USD
+0.260+3.06%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
128.08MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Imunon Inc Unternehmen
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. The Company is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit a strong immunological response. The third modality, FixPlas, concerns the application of Imunon’s DNA technology to produce universal cancer vaccines, also called tumor associated antigen cancer vaccines. The fourth modality, IndiPlas, is in the discovery phase and is focused on the development of personalized cancer vaccines, or neoepitope cancer vaccines. Its lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer.
Unternehmensinformationen
BörsenkürzelIMNN
Name des UnternehmensImunon Inc
IPO-datumOct 27, 1993
CEODr. Stacy R. Lindborg, Ph.D.
Anzahl der mitarbeiter25
WertpapierartOrdinary Share
GeschäftsjahresendeOct 27
Addresse997 Lenox Dr Ste 100
StadtLAWRENCEVILLE
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl08648
Telefon16098969100
Websitehttps://imunon.com/
BörsenkürzelIMNN
IPO-datumOct 27, 1993
CEODr. Stacy R. Lindborg, Ph.D.
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael H. Tardugno
Mr. Michael H. Tardugno
Executive Chairman of the Board
Executive Chairman of the Board
4.91K
+6.62%
Dr. Khursheed Anwer, Ph.D.
Dr. Khursheed Anwer, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
2.97K
+246.67%
Dr. Donald P. Braun, Ph.D.
Dr. Donald P. Braun, Ph.D.
Independent Director
Independent Director
1.71K
--
Mr. Frederick J. (Fred) Fritz
Mr. Frederick J. (Fred) Fritz
Independent Director
Independent Director
784.00
--
Ms. Kimberly Graper
Ms. Kimberly Graper
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan Eylward
Ms. Susan Eylward
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Douglas Vincent Faller, M.D., Ph.D.
Dr. Douglas Vincent Faller, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Independent Director
Independent Director
--
--
Mr. James E. Dentzer
Mr. James E. Dentzer
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael H. Tardugno
Mr. Michael H. Tardugno
Executive Chairman of the Board
Executive Chairman of the Board
4.91K
+6.62%
Dr. Khursheed Anwer, Ph.D.
Dr. Khursheed Anwer, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
2.97K
+246.67%
Dr. Donald P. Braun, Ph.D.
Dr. Donald P. Braun, Ph.D.
Independent Director
Independent Director
1.71K
--
Mr. Frederick J. (Fred) Fritz
Mr. Frederick J. (Fred) Fritz
Independent Director
Independent Director
784.00
--
Ms. Kimberly Graper
Ms. Kimberly Graper
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan Eylward
Ms. Susan Eylward
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Sat, Jul 26
Aktualisiert: Sat, Jul 26
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Intracoastal Capital, L.L.C.
3.49%
Geode Capital Management, L.L.C.
0.45%
Tardugno (Michael H)
0.23%
BlackRock Institutional Trust Company, N.A.
0.18%
Le (Goff Corinne)
0.17%
Other
95.48%
Aktionäre
Aktionäre
Anteil
Intracoastal Capital, L.L.C.
3.49%
Geode Capital Management, L.L.C.
0.45%
Tardugno (Michael H)
0.23%
BlackRock Institutional Trust Company, N.A.
0.18%
Le (Goff Corinne)
0.17%
Other
95.48%
Aktionärstypen
Aktionäre
Anteil
Corporation
3.49%
Individual Investor
0.76%
Investment Advisor/Hedge Fund
0.69%
Investment Advisor
0.34%
Venture Capital
0.07%
Hedge Fund
0.05%
Other
94.61%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
52
134.45K
5.49%
-36.41K
2025Q1
50
565.85K
3.09%
-1.96M
2024Q4
52
608.75K
4.16%
-1.78M
2024Q3
50
1.20M
8.34%
-536.74K
2024Q2
48
484.50K
4.81%
-359.07K
2024Q1
49
447.12K
4.68%
-585.60K
2023Q4
59
755.78K
7.96%
-79.04K
2023Q3
65
452.55K
4.85%
-471.22K
2023Q2
68
440.18K
4.85%
-489.81K
2023Q1
80
515.97K
6.03%
-572.90K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Intracoastal Capital, L.L.C.
1.11M
5.22%
+1.11M
--
May 28, 2025
Geode Capital Management, L.L.C.
143.44K
0.67%
+3.93K
+2.82%
Mar 31, 2025
Tardugno (Michael H)
73.71K
0.35%
+4.57K
+6.61%
May 13, 2025
BlackRock Institutional Trust Company, N.A.
58.22K
0.27%
--
--
Mar 31, 2025
Le (Goff Corinne)
53.00K
0.25%
--
--
May 13, 2025
The Vanguard Group, Inc.
48.81K
0.23%
--
--
Mar 31, 2025
Anwer (Khursheed)
44.56K
0.21%
+31.71K
+246.67%
May 13, 2025
Lindborg (Stacy R. Ph.D.)
28.06K
0.13%
--
--
May 13, 2025
Braun (Donald P)
25.60K
0.12%
--
--
May 13, 2025
XTX Markets LLC
21.68K
0.1%
+271.00
+1.27%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Datum
Art
Verhältnis
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
